id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-E-0131-0008,FDA,FDA-2014-E-0131,180 Day Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-11-18T05:00:00Z,2015,11,2015-11-18T05:00:00Z,,2015-11-18T19:20:54Z,,0,0,0900006481d5747c
FDA-2014-E-0131-0007,FDA,FDA-2014-E-0131,"Determination of Regulatory Review Period for Purposes of Patent
Extension; COMETRIQ",Notice,Determinations,2015-04-22T04:00:00Z,2015,4,2015-04-22T04:00:00Z,2015-10-20T03:59:59Z,2015-04-22T14:54:27Z,2015-09302,0,0,0900006481ab368c
FDA-2014-E-0131-0006,FDA,FDA-2014-E-0131,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-03-31T04:00:00Z,2015,3,2015-03-31T04:00:00Z,,2015-03-31T18:24:31Z,,0,0,0900006481a7e149
FDA-2014-E-0131-0005,FDA,FDA-2014-E-0131,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2015-02-27T05:00:00Z,2015,2,2015-02-27T05:00:00Z,,2015-02-27T14:15:30Z,,0,0,0900006481a1ba53